This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
LifePoint (LPNT) Sells Unit to Focus on High-Growth Markets
by Zacks Equity Research
LifePoint (LPNT) continues its inorganic growth via divestitures and acquisitions.
Mednax Suffers From Low Patient Admissions, High Expenses
by Zacks Equity Research
The stock of Mednax (MD) is possibly suffering from decline in business volumes along with cost inflation.
Should Value Investors Consider LifePoint Health (LPNT) Stock?
by Zacks Equity Research
LipePoint is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
LifePoint Health (LPNT) Down 4.8% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
LifePoint Health (LPNT) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Investors Should Offload LifePoint (LPNT) Stock
by Zacks Equity Research
LifePoint's (LPNT) lowerng of earnings guidance, soft patient volumes, soaring expenses, poor visibility for future earnings performance hurts the stock
LifePoint Health (LPNT) Q2 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
LifePoint Health's (LPNT) second-quarter earnings were driven by lower expenses.
Obamacare Replacement Bill Revised: Hospital Stocks in Focus
by Zacks Equity Research
Senate Republican leaders released a revised plan for President Donald Trump's health care reform on Jul 13.
LifePoint (LPNT) Thriving on Inorganic Growth, Ample Capital
by Zacks Equity Research
LifePoint Health Inc. (LPNT) is well poised to grow over the long term given a number of acquisitions made over the past few years.
Is LifePoint Health (LPNT) a Great Stock for Value Investors?
by Zacks Equity Research
LifePoint is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Community Health (CYH) Continues to Divest, Aligns Business
by Zacks Equity Research
Community Health Systems, Inc. (CYH) has signed a definitive agreement to sell five Pennsylvania hospitals.
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
HCA Holdings (HCA) Q1 Earnings In Line, Guidance Intact
by Zacks Equity Research
HCA Holdings Inc. (HCA) earnings of $1.74 per share, met the Zacks Consensus Estimate and grew 1.8% year over year.
LifePoint Grows Inorganically Yet Stock Suffers: Here's Why
by Zacks Equity Research
Despite its efforts to grow inorganically, LifePoint's shares returned 15.2% compared with a 31% gain for the Zacks categorized Medical Hospital industry over the past three years.
Obamacare Replacement Bill Pulled: Hospital Stocks Rally
by Arpita Dutt
Hospital stocks like Tenet Healthcare (THC) rallied after a bill to repeal and replace Obamacare was pulled.
Is Lifepoint Health a Suitable Stock for Value Investors?
by Zacks Equity Research
Let's focus on Lifepoint Health, Inc. (LPNT) stock into this equation and find out if it is a good choice for value-oriented investors right now or not.
Are Hospital Stocks in Trouble if Obamacare Is Replaced?
by Zacks Equity Research
The Trump administration is steadily moving toward restructuring the federal health-care law.
6 Reasons to Shun Tenet Healthcare (THC) Stock For Now
by Zacks Equity Research
Other than industry-related uncertainty, Tenet Healthcare stock is facing pressure from internal headwinds.
Universal Health (UHS) Beats on Q4 Earnings, Gives '17 View
by Zacks Equity Research
Universal Health's (UHS) better-than-expected fourth quarter earnings was driven by revenue growth.
4 Reasons Why HCA Holdings (HCA) is an Attractive Choice
by Zacks Equity Research
HCA Holdings Inc. (HCA) still remains a solid bet owing to its vast scale, operational strength and strong cash flows.
Is it the Right Time to Offload LifePoint Health (LPNT) Stock?
by Zacks Equity Research
LifePoint Health Inc. (LPNT) seems to have fallen on hard times due to multiple headwinds like unprofitable acquisitions, decline in enrollment and rising level of bad debts over the last few years.
HCA Holdings Holds Promise Despite Headwinds: Here's Why
by Zacks Equity Research
The uptrend in HCA Holdings Inc. (HCA) explains its attractiveness in an uncertainty-ridden industry.
Life Point Health Strategic Acquisitions Impresses Amid Risks
by Zacks Equity Research
Year to date, shares of the company have tanked by 21.3% compared with the Zacks categorized Medical Hospital industry's decline of 9%
Adeptus Health (ADPT) Shares Continue to Fall: Here's Why
by Zacks Equity Research
Shares of Adeptus Health, Inc. (ADPT) have been severely underperforming. This is evidenced by the fact that the stock has lost 85.7% year to date
HCA Holdings Well Poised for Growth In Spite of Headwinds
by Zacks Equity Research
HCA Holdings (HCA) scale and diversified business mix provides it a competitive advantage.
Universal Health to Buy Cambian Group Arm for UK Expansion
by Zacks Equity Research
In an effort to expand its presence in the U.K., Universal Health Services, Inc. (UHS) is planning to buy the adult services division of Cambian Group.